Insider Sale: BLND Head of Legal sold 4,000 Class A shares via 10b5-1 plan
Rhea-AI Filing Summary
Winnie Ling, Head of Legal and People at Blend Labs, reported a sale of 4,000 shares of Class A common stock on 08/07/2025. The sale was executed under a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2025. The filing reports a weighted average sale price of $3.6192 per share, with sale prices ranging from $3.61 to $3.645 per share and notes that a breakdown of shares sold at each price is available on request.
Following the reported transaction Ling directly beneficially owns 372,018 shares. The disposal reduced her pre-sale direct holding by roughly 1.06%, consistent with a modest, preplanned disposition under an established trading plan rather than an ad hoc sale.
Positive
- Transaction was executed under a Rule 10b5-1 trading plan adopted on March 14, 2025, indicating a preplanned disposition and supporting regulatory compliance
- Reporting person retains a substantial direct holding of 372,018 Class A shares after the sale
Negative
- None.
Insights
TL;DR: Small, preplanned insider sale under a 10b5-1 plan; modest size relative to reported holdings.
The Form 4 discloses a 4,000-share sale at a weighted average price of $3.6192, executed under a Rule 10b5-1 plan adopted March 14, 2025. Post-transaction direct ownership is 372,018 shares, implying the sale reduced pre-sale holdings by about 1.06%. From a financial-significance perspective, this is a routine, small-scale liquidity event that is unlikely to materially affect the company’s capitalization or signal a change in operating outlook based solely on the disclosed facts.
TL;DR: Transaction follows a documented 10b5-1 plan, which supports disclosure and compliance practices.
The report specifically states the sale was made pursuant to a Rule 10b5-1 trading plan, including the plan adoption date and a weighted average price range. That transparency is consistent with good insider-trading governance because it identifies the sale as preplanned. The filing also offers to provide the per-price breakdown on request, which aids regulatory and shareholder review. No other governance events or departures are disclosed in the document.
FAQ
What did the Blend Labs (BLND) insider file report?
How many BLND shares does the reporting person hold after the sale?
Was the sale at BLND unusual or preplanned?
What was the sale price range disclosed in the BLND Form 4?
Can I get a breakdown of how many shares were sold at each price?